InvestorsHub Logo

docoroc2

08/24/16 9:55 AM

#278 RE: Whos_Who #277

Yes, I read this. Interestingly, the trial will only take 12 weeks, so this stock could move quickly before EOY. SP is cheap, given huge market for acne. Avoids systemic side effects of minocycline/Accutane, potentially. Should be on everyone's radar who follows biotechs, IMHO.